Get the Stockscreener App
1.67
2.45%
0.04
Traws Pharma Inc stock is traded at $1.67, with a volume of 101.65K.
It is up +2.45% in the last 24 hours and up +9.87% over the past month.
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
See More
Previous Close:
$1.63
Open:
$1.63
24h Volume:
101.65K
Relative Volume:
0.09
Market Cap:
$9.29M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+9.87%
1M Performance:
+9.87%
6M Performance:
-75.07%
1Y Performance:
-81.94%
1-Day Range:
$1.59
$1.71
1-Week Range:
$1.45
$1.71
52-Week Range:
$0.97
$19.44
Traws Pharma Inc Stock (TRAW) Company Profile
Name
Traws Pharma Inc
Sector
Industry
Phone
267-759-3680
Address
12 PENNS TRAIL, NEWTOWN
Compare TRAW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRAW
Traws Pharma Inc
|
1.67 | 9.01M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.10 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.54 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.45 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.55 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
306.79 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-22 | Initiated | Ladenburg Thalmann | Buy |
| May-18-21 | Initiated | Guggenheim | Buy |
| Mar-01-18 | Reiterated | H.C. Wainwright | Buy |
| Jan-17-18 | Downgrade | Maxim Group | Buy → Hold |
| Oct-09-17 | Initiated | H.C. Wainwright | Buy |
| Apr-27-17 | Initiated | Laidlaw | Buy |
| Jul-01-15 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-15 | Initiated | H.C. Wainwright | Buy |
View All
Traws Pharma Inc Stock (TRAW) Latest News
How to integrate Traws Pharma Inc. into portfolio analysis toolsMarket Growth Report & Community Consensus Stock Picks - Newser
Best data tools to analyze Traws Pharma Inc. stock2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser
What machine learning models say about Traws Pharma Inc.July 2025 Weekly Recap & Fast Gain Stock Trading Tips - Newser
How to build a custom watchlist for Traws Pharma Inc.Weekly Trade Summary & Technical Pattern Based Signals - Newser
Institutional scanner results for Traws Pharma Inc. [Quarterly Trade Review]Stock Portfolio Risk Control - Newser
How Traws Pharma Inc. stock performs during market volatilityTechnical Analysis of Growth Stock Opportunities - Newser
How to monitor Traws Pharma Inc. with trend dashboardsAlgorithmic Forecast for Swing Trading Picks - Newser
How to use a screener to detect Traws Pharma Inc. breakoutsNeural Network Based Equity Prediction System - Newser
Can machine learning forecast Traws Pharma Inc. recovery5-Year Price Trend Summary and Analysis - Newser
Using Python tools to backtest Traws Pharma Inc. strategiesQuick Profit Setup with Signal Forecast - Newser
Traws Pharma TRAW 2025Q2 Earnings Preview Upside Potential on Expected Revenue Growth - AInvest
Using R and stats models for Traws Pharma Inc. forecastingFree Investment Strategy With Predictable Gains - Newser
Watch for Bullish Crossover in Traws Pharma Inc.Consistent Profit Pattern Recognition Tools Shared - metal.it
Can Traws Pharma Inc. stock recover from recent declineBuy Opportunity Forecast for Fast Traders - Newser
Intraday pattern recognizer results for Traws Pharma Inc.Capital Growth Plan for New Investors - Newser
Traws Pharma to Announce Q2 Results and Business Update on August 14 - MSN
Is Traws Pharma Inc. stock a value trapCapital Doubling Stock Strategy - kangso.co.kr
What makes Traws Pharma Inc. stock price move sharplyConsistent Gain Plan with AI Support - Newser
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025 - GlobeNewswire
Traws Pharma Earnings: Respiratory Viral Disease Pioneer Reports Q2 Results Next Week - Stock Titan
Can Traws Pharma Inc. Outperform Peers After Recent PullbackSwing Trading Plan With Smart Signals in Review - beatles.ru
Drawdown in Traws Pharma Inc. May Be Nearing EndAI Forecast Accuracy Evaluation Insight - beatles.ru
How strong is Traws Pharma Inc. company’s balance sheetTap into rapid wealth building techniques - Jammu Links News
Is Traws Pharma Inc. a good long term investmentUnlock exclusive trading strategies for gains - Jammu Links News
Why is Traws Pharma Inc. stock attracting strong analyst attentionSuperior trading gains - Jammu Links News
Does Traws Pharma Inc. stock perform well during market downturnsLightning-fast growth - Jammu Links News
What are Traws Pharma Inc. company’s key revenue driversFree Risk Assessment Services - Jammu Links News
What catalysts could drive Traws Pharma Inc. stock higher in 2025Free Capital Allocation Plans - Jammu Links News
How does Traws Pharma Inc. compare to its industry peersCapitalize on high-growth stocks early - Jammu Links News
What is Traws Pharma Inc. company’s growth strategyExceptional earning trajectories - Jammu Links News
What is the dividend policy of Traws Pharma Inc. stockHigh-yield capital appreciation - Jammu Links News
What institutional investors are buying Traws Pharma Inc. stockDiscover stock picks with superior returns - Jammu Links News
What markets is CORT expanding into Is Traws Pharma Inc. stock a good long term investment optionFree Buy/Sell Signal Notifications - Jammu Links News
What analysts say about Traws Pharma Inc. stockInvest in stocks with strong fundamentals - Jammu Links News
What are the latest earnings results for Traws Pharma Inc.Breakout portfolio performance - Jammu Links News
Is Traws Pharma Inc. a growth stock or a value stockExceptional market performance - Jammu Links News
When is Traws Pharma Inc. stock expected to show significant growthConsistently superior profits - Jammu Links News
Exit strategy if you’re trapped in Traws Pharma Inc.Stock Forecast Tools for Retail Traders - Newser
Institutional scanner results for Traws Pharma Inc.Weekly Hot Stocks Based on Volume Flow - Newser
How many analysts rate Traws Pharma Inc. as a “Buy”Top Growth Alerts For Smart Trading - Jammu Links News
Traws Pharma Inc Stock (TRAW) Financials Data
There is no financial data for Traws Pharma Inc (TRAW). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):